Back to Authors

Mohr, Sydney

A5042288477 | I4210087915

Mayo Clinic

Massachusetts General Hospital

Citations 1

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Blood | July 8, 2022 | Volume: 140 | Issue: 16 | Pages: 1822-1826

10.1182/blood.2022015443 | PMID 35802834